Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin
Open Access
- 1 February 1999
- journal article
- clinical trial
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 106 (2) , 102-107
- https://doi.org/10.1111/j.1471-0528.1999.tb08208.x
Abstract
Objective To study the obstetric course of women with a history of recurrent miscarriage associated with antiphospholipid antibodies, lupus anticoagulant and anticardiolipin antibodies, treated with low dose aspirin and low dose heparin. Design Prospective observational study. Setting University based tertiary referral clinic. Population One hundred and fifty pregnant women with a history of recurrent miscarriage associated with persistently positive tests for antiphospholipid antibodies. Methods Lupus anticoagulant was detected using the dilute Russell's viper venom time together with a platelet neutralisation procedure. IgG and IgM anticardiolipin antibodies were detected using a standardised enzyme linked immunosorbent assay. An IgG anticardiolipin level ≥5 per litre units and an IgM anticardiolipin level ≥3 per litre units was considered positive. Aspirin (75 mg daily) was commenced at the time of a positive pregnancy test and heparin (5000 units subcutaneously 12 hourly, or enoxaparin 20 mg daily) was started when fetal heart activity was demonstrated on ultrasound. Treatment was stopped at the time of miscarriage or at 34 weeks of gestation. Results One hundred and seven pregnancies (71%) resulted in a live birth. Forty‐one pregnancies (27%) miscarried, the majority in the first trimester. One woman had a stillbirth, and one a premature baby who died in the neonatal period. One pregnancy was terminated for a fetal anomaly. Gestational hypertension complicated 17% (18/108) of ongoing pregnancies and antepartum haemorrhage 7% (8/108). Twenty‐six babies (24%) were delivered before 37 weeks of gestation. Fifty women (46%) were delivered by caesarean section. The median birthweight of all live born infants was 3069 g (range 5314300); however 15% (16/108) of the infants were small for gestational age. Conclusion Combination treatment with aspirin and heparin leads to a high live birth rate among women with recurrent miscarriage and antiphospholipid antibodies. However, successful pregnancies are prone to a high risk of complications during all trimesters. Close antenatal surveillance and planned delivery of these pregnancies in a unit with specialist obstetric and neonatal intensive care facilities are indicated.Keywords
This publication has 25 references indexed in Scilit:
- Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic MechanismNew England Journal of Medicine, 1997
- Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosisJournal of Bone and Mineral Research, 1996
- Antiphospholipid antibody–associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin aloneAmerican Journal of Obstetrics and Gynecology, 1996
- The effect of aspirin and indomethacin on prostacyclin and thromboxone production by placental tissue incubated with immunoglobulin G fractions from patients with lupus anticoagulantAmerican Journal of Obstetrics and Gynecology, 1995
- In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotrophin releasing hormonedependent human chorionic gonadotrophin release by cultured trophoblast cellsPlacenta, 1995
- ACP Broadsheet no 136: February 1993. Detection and importance of anticardiolipin antibodies.Journal of Clinical Pathology, 1993
- Antiphospholipid Antibodies in PregnancyAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1992
- LUPUS ANTICOAGULANT AND RECURRENT FETAL LOSS: SUCCESSFUL TREATMENT WITH GAMMAGLOBULINThe Lancet, 1988
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982